Centene, Humana sue Merck for ‘monopolistic scheme’ to delay generics of blockbuster cholesterol drug
Centene and Humana filed separate lawsuits against Merck alleging the drugmaker’s “monopolistic scheme” delayed generic versions of its blockbuster cholesterol drug Zetia from coming to market, causing the insurers to pay higher prices for years. The suits by two of the biggest health insurers were filed in similar but separate lawsuits Wednesday in federal court in… Read More »